• Derivatives Summary :

FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82

GST Council Meeting Outcome

India Infoline News Service Sep-20-2019

GST council meeting concludes, steps taken to boost tourism.

European markets down, Asian markets end higher on PBOC rate cut

India Infoline News Service Sep-20-2019

The People's Bank of China set the one-year Loan Prime Rate at 4.2%, down from 4.25% in August, the second small rate cut in two months in its efforts to pump up the economy.

FM's tax relief leads to blockbuster day for D-street

India Infoline News Service Sep-20-2019

All sectoral indices, except IT, ended in the green as investors cheered the long-overdue tax relief India Inc. had been demanding.

Lupin gets approval from USFDA for Levothyroxine Sodium tablets

India Infoline News Service Sep-20-2019

With this ANDA approval, Lupin's Levothyroxine Sodium Tablets USP, 2S meg, SO meg, 7S meg, 88 meg, 100 meg, 112 meg, 125 meg, 137 meg, 1SO meg, 17S meg, 200 meg, and 300 meg are now AB rated (therapeutically equivalent) with Reference Listed Drugs, SYNTHROID and UNITHROID.

Nippon Express to acquire 22% stake in Future Supply

India Infoline News Service Sep-20-2019

Nippon Express will also have representation on FSCs Board of Directors, which will further strengthen its Board through their strategic direction.

USFDA clears Unichem Lab Kolhapur unit with no observations; stock spikes 3%

India Infoline News Service Sep-20-2019

The inspection was a cGMP surveillance and pre-approval inspection and was successfully concluded without any FDA form 483 issued, the company added.